Renovacor
0 followers
Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment of Marc Semigran, M.D., as ch... Read more
Org chart
Magdalene Cook
President & CEO
Magdalene Cook
Collapse
Marc Semigran
Chief Medical Officer
Matt Killeen
Chief Scientific Officer
Jiwen Zhang
Chief Regulatory Officer
Beth White
Chief Business Officer & SVP, Operations
Kumar Dhanasekharan
SVP, Technical Operations
Teams
View all
